8-K Announcements
6Material company update
May 8, 2026·SEC
Material company update
Mar 10, 2026·SEC
Material company update
Nov 18, 2025·SEC
Ultralife Corporation(ULBI)Earnings, Financials & Key Ratios
ULBI•NASDAQ
Price updated Jun 19, 2026
AboutUltralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables. The Communications Systems segment provides communications systems and accessories to support military communications systems, such as radio frequency amplifiers, power supplies and cables, connector assemblies, amplified speakers, equipment mounts, case equipment, man-portable systems, and integrated communication systems for fixed or vehicle applications comprising vehicle adapters, vehicle installed power enhanced rifleman appliqué systems, and SATCOM systems. This segment's military communications systems and accessories are designed to enhance and extend the operation of communications equipment, such as vehicle-mounted, manpack, and handheld transceivers. It sells its products under the Ultralife, Ultralife Thin Cell, Utralife HiRate, Ultralife and design, Ultra, Lithium Power, LithiumPower and Design, McDowell Research, AMTI, ABLE, ACCUTRONICS, ACCUPRO, ENTELLION, SWE Southwest Electronic Energy Group, SWE DRILL-DATA, and SWE SEASAFE brands through original equipment manufacturers, and industrial and defense supply distributors, as well as directly to the United States and international defense departments. In addition, the company sells its 9-volt battery to the broader consumer market through national and regional retail chains and online retailers. Ultralife Corporation serves government, defense, and commercial sectors. The company was incorporated in 1990 and is headquartered in Newark, New York.Show more
- Revenue$191M+16.2%
- EBITDA$15M+4.2%
- Net Income-$6M-193.4%
- EPS (Diluted)-0.35-192.1%
- Gross Margin23.28%-9.5%
- EBITDA Margin7.7%-10.3%
- Operating Margin4.82%-20.4%
- Net Margin-3.09%-180.4%
- ROE-4.46%-191.8%
ULBI Key Insights
Ultralife Corporation (ULBI) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Strong 5Y sales CAGR of 12.2%
- ✓Trading at only 0.8x book value
✗Weaknesses
- ✗Weak 3Y average ROE of 2.1%
- ✗Thin 5Y average net margin of 1.0%
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when ULBI posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
ULBI Price & Volume
Ultralife Corporation (ULBI) stock price & volume — 10-year historical chart
Loading chart...
ULBI Growth Metrics
Ultralife Corporation (ULBI) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years9.6%
5 Years12.16%
3 Years13.18%
TTM8.42%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-255.39%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-257.02%
Return on Capital
10 Years4.87%
5 Years3.46%
3 Years5.73%
Last Year4.97%
ULBI Recent Earnings
Ultralife Corporation (ULBI) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 3/12 qtrs (25%)●Beat Revenue 5/12 qtrs (42%)
Q2 2026Latest
May 8, 2026Metric
Actual
Est
EPS
$0.03-120.0%
$0.15
Rev
$47M-9.5%
$52M
Q2 2026
Mar 10, 2026Metric
Actual
Est
EPS
$0.12-50.0%
$0.24
Rev
$48M-14.9%
$57M
Q4 2025
Nov 18, 2025Metric
Actual
Est
EPS
$0.07-133.3%
$0.21
Rev
$43M-18.2%
$53M
Q3 2025
Aug 7, 2025Metric
Actual
Est
EPS
$0.07-68.2%
$0.22
Rev
$49M-8.4%
$53M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 8, 2026 | $0.03vs $0.15-120.0% | $47Mvs $52M-9.5% |
| Q2 2026 | Mar 10, 2026 | $0.12vs $0.24-50.0% | $48Mvs $57M-14.9% |
| Q4 2025 | Nov 18, 2025 | $0.07vs $0.21-133.3% | $43Mvs $53M-18.2% |
| Q3 2025 | Aug 7, 2025 | $0.07vs $0.22-68.2% | $49Mvs $53M-8.4% |
Based on last 12 quarters of dataView full earnings history →
ULBI Peer Comparison
Ultralife Corporation (ULBI) competitors in Battery Packs and Energy Storage Systems — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 FLUX | 15.06M | 0.86 | -2.15 | 9.22% | -12.48% | -7.38% | ||
 CBAT | 60.59M | 0.68 | -6.84 | 10.52% | -7.43% | -0.06% | 0.00 | |
 MVST | 429.77M | 1.29 | -14.33 | 12.56% | -11.52% | -10.76% | 0.45 | |
 CLFD | 553.57M | 40.45 | -69.74 | 19.56% | -6.32% | -3.4% | 0.03 | |
 LIQT | 8.95M | 0.90 | -1.01 | 13.03% | -55.45% | -79.65% | 1.67 | |
 BWEN | 117.72M | 5.03 | 21.87 | 10.42% | 3.3% | 7.92% | 0.43 | |
 ENR | 1.47B | 21.52 | 6.48 | 2.28% | 6.55% | 116.9% | 20.79 | |
 DRS | 12.29B | 46.08 | 44.74 | 12.8% | 7.85% | 10.79% | 0.17 |
Compare ULBI vs Peers
Ultralife Corporation (ULBI) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
ULBI Income Statement
Ultralife Corporation (ULBI) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 85.53M | 87.19M | 106.8M | 107.71M | 98.27M | 131.84M | 158.64M | 164.46M | 191.16M | 187.86M |
Revenue Growth % | 3.72% | 1.94% | 22.49% | 0.86% | -8.77% | 34.17% | 20.33% | 3.66% | 16.24% | 8.42% |
Cost of Goods Sold | 59.3M | 61.61M | 75.63M | 78.55M | 73.63M | 102.44M | 119.44M | 122.14M | 146.66M | 145.85M |
COGS % of Revenue | 69.33% | 70.66% | 70.82% | 72.93% | 74.92% | 77.7% | 75.29% | 74.27% | 76.72% | - |
Gross Profit | 26.23M▲ 0% | 25.58M▼ 2.5% | 31.16M▲ 21.8% | 29.16M▼ 6.4% | 24.64M▼ 15.5% | 29.4M▲ 19.3% | 39.2M▲ 33.3% | 42.31M▲ 7.9% | 44.5M▲ 5.2% | 42.01M▲ 0% |
Gross Margin % | 30.67% | 29.34% | 29.18% | 27.07% | 25.08% | 22.3% | 24.71% | 25.73% | 23.28% | 22.36% |
Gross Profit Growth % | 4.48% | -2.47% | 21.82% | -6.44% | -15.49% | 19.31% | 33.33% | 7.94% | 5.17% | - |
Operating Expenses | 19.76M | 19.03M | 23.8M | 23.46M | 24.61M | 29.27M | 29.73M | 32.35M | 35.28M | 38.15M |
OpEx % of Revenue | 23.1% | 21.82% | 22.28% | 21.78% | 25.04% | 22.2% | 18.74% | 19.67% | 18.46% | - |
Selling, General & Admin | 15.02M | 14.52M | 16.99M | 17.51M | 17.78M | 22.19M | 22.19M | 24.08M | 26.28M | 28.22M |
SG&A % of Revenue | 17.56% | 16.65% | 15.91% | 16.26% | 18.09% | 16.83% | 13.99% | 14.64% | 13.75% | - |
Research & Development | 4.74M | 4.51M | 6.8M | 5.95M | 6.83M | 7.08M | 7.53M | 8.27M | 9M | 9.93M |
R&D % of Revenue | 5.54% | 5.17% | 6.37% | 5.52% | 6.95% | 5.37% | 4.75% | 5.03% | 4.71% | - |
Other Operating Expenses | -181K | 58K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income | 6.48M▲ 0% | 6.55M▲ 1.2% | 7.37M▲ 12.4% | 5.7M▼ 22.6% | 35K▼ 99.4% | 129K▲ 268.6% | 9.47M▲ 7245.0% | 9.96M▲ 5.2% | 9.22M▼ 7.5% | 3.85M▲ 0% |
Operating Margin % | 7.57% | 7.52% | 6.9% | 5.29% | 0.04% | 0.1% | 5.97% | 6.06% | 4.82% | 2.05% |
Operating Income Growth % | 72.1% | 1.22% | 12.4% | -22.62% | -99.39% | 268.57% | 7244.96% | 5.17% | -7.48% | - |
EBITDA | 8.9M | 8.92M | 10.11M | 8.64M | 3.57M | 4.59M | 13.39M | 14.12M | 14.72M | 9.32M |
EBITDA Margin % | 10.41% | 10.24% | 9.47% | 8.02% | 3.64% | 3.48% | 8.44% | 8.59% | 7.7% | 4.96% |
EBITDA Growth % | 37.2% | 0.24% | 13.32% | -14.61% | -58.62% | 28.37% | 191.76% | 5.5% | 4.23% | -32.7% |
D&A (Non-Cash Add-back) | 2.43M | 2.37M | 2.75M | 2.94M | 3.54M | 4.46M | 3.91M | 4.16M | 5.5M | 5.46M |
EBIT | 6.48M | 6.55M | 7.31M | 7.46M | 91K | 505K | 11.13M | 10.24M | 9.22M | 3.85M |
Net Interest Income | -183K | -63K | -539K | -436K | -242K | -951K | -2.02M | -1.94M | -3.95M | -3.79M |
Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 183K | 63K | 539K | 436K | 242K | 951K | 2.02M | 1.94M | 3.95M | 3.79M |
Other Income/Expense | -181K | 58K | -597K | 1.32M | -186K | -575K | -358K | -1.66M | -17.62M | -15.36M |
Pretax Income | 6.29M▲ 0% | 6.61M▲ 5.1% | 6.77M▲ 2.4% | 7.02M▲ 3.7% | -151K▼ 102.2% | -446K▼ 195.4% | 9.12M▲ 2144.2% | 8.3M▼ 9.0% | -8.4M▼ 201.2% | -11.51M▲ 0% |
Pretax Margin % | 7.36% | 7.58% | 6.34% | 6.52% | -0.15% | -0.34% | 5.75% | 5.05% | -4.39% | -6.13% |
Income Tax | -1.37M | -18.39M | 1.46M | 1.69M | 79K | -326K | 1.95M | 1.89M | -2.45M | -3.21M |
Effective Tax Rate % | -21.75% | -278.03% | 21.52% | 24.09% | -52.32% | 73.09% | 21.4% | 22.79% | 29.14% | 27.86% |
Net Income | 7.65M▲ 0% | 24.93M▲ 226.0% | 5.21M▼ 79.1% | 5.23M▲ 0.5% | -234K▼ 104.5% | -119K▲ 49.1% | 7.2M▲ 6147.9% | 6.31M▼ 12.3% | -5.9M▼ 193.4% | -8.21M▲ 0% |
Net Margin % | 8.94% | 28.59% | 4.87% | 4.86% | -0.24% | -0.09% | 4.54% | 3.84% | -3.09% | -4.37% |
Net Income Growth % | 117.95% | 225.97% | -79.12% | 0.52% | -104.47% | 49.15% | 6147.9% | -12.3% | -193.44% | -255.39% |
Net Income (Continuing) | 7.66M | 25M | 5.31M | 5.33M | -230K | -120K | 7.17M | 6.41M | -5.95M | -8.3M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | -154K | -85K | 24K | 123K | 127K | 126K | 95K | 192K | 139K | 119K |
EPS (Diluted) | 0.48▲ 0% | 1.53▲ 218.8% | 0.32▼ 79.1% | 0.33▲ 3.1% | -0.01▼ 104.4% | -0.01▲ 49.3% | 0.44▲ 6045.9% | 0.38▼ 13.6% | -0.35▼ 192.1% | -0.49▲ 0% |
EPS Growth % | 108.7% | 218.75% | -79.09% | 3.13% | -104.42% | 49.32% | - | -13.64% | -192.11% | -257.02% |
EPS (Basic) | 0.49 | 1.57 | 0.33 | 0.33 | -0.01 | -0.01 | 0.44 | 0.38 | -0.35 | - |
Diluted Shares Outstanding | 15.86M | 16.35M | 16.18M | 16.1M | 16.04M | 16.13M | 16.23M | 16.77M | 16.64M | 16.66M |
Basic Shares Outstanding | 15.53M | 15.88M | 15.78M | 15.9M | 16.04M | 16.13M | 16.36M | 16.55M | 16.64M | 16.66M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
ULBI Balance Sheet
Ultralife Corporation (ULBI) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 61.92M | 67.22M | 70.37M | 64.5M | 66.52M | 78.99M | 90.2M | 97.16M | 105.8M | 110.1M |
Cash & Short-Term Investments | 18.33M | 25.93M | 7.41M | 10.65M | 8.41M | 5.71M | 10.28M | 6.85M | 9.35M | 8.89M |
Cash Only | 18.33M | 25.93M | 7.41M | 10.65M | 8.41M | 5.71M | 10.28M | 6.85M | 9.35M | 8.89M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 14.66M | 16.02M | 30.11M | 21.05M | 20.23M | 27.78M | 31.76M | 29.37M | 33.95M | 34.43M |
Days Sales Outstanding | 62.55 | 67.04 | 102.9 | 71.34 | 75.15 | 76.91 | 73.07 | 65.18 | 64.82 | 63.94 |
Inventory | 26.33M | 22.84M | 29.76M | 28.19M | 33.19M | 41.19M | 42.22M | 51.36M | 54.01M | 57.29M |
Days Inventory Outstanding | 162.04 | 135.34 | 143.62 | 131 | 164.54 | 146.77 | 129 | 153.49 | 134.42 | 134.27 |
Other Current Assets | 89K | 0 | 0 | 1.59M | 4.69M | 4.3M | 0 | 0 | 8.5M | 9.5M |
Total Non-Current Assets | 35.27M | 52.88M | 74.18M | 73.2M | 93.01M | 89.44M | 88.07M | 123.29M | 111.11M | 110.53M |
Property, Plant & Equipment | 7.57M | 10.74M | 22.52M | 22.85M | 25.79M | 23.9M | 24.71M | 44.64M | 40.4M | 40.12M |
Fixed Asset Turnover | 11.30x | 8.12x | 4.74x | 4.71x | 3.81x | 5.52x | 6.42x | 3.68x | 4.73x | 4.45x |
Goodwill | 20.46M | 20.11M | 26.75M | 27.02M | 38.07M | 37.43M | 37.57M | 45.01M | 45.38M | 45.33M |
Intangible Assets | 7.08M | 6.5M | 9.72M | 9.21M | 17.39M | 15.92M | 15.11M | 24.56M | 10.93M | 10.65M |
Long-Term Investments | -157K | -82K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 125K | 82K | 1.96M | 2.29M | 298K | 121K | 122K | 9.09M | 3.91M | 3.67M |
Total Assets | 97.19M▲ 0% | 120.1M▲ 23.6% | 144.56M▲ 20.4% | 137.7M▼ 4.7% | 159.54M▲ 15.9% | 168.43M▲ 5.6% | 178.28M▲ 5.8% | 220.45M▲ 23.7% | 216.91M▼ 1.6% | 220.63M▲ 0% |
Asset Turnover | 0.88x | 0.73x | 0.74x | 0.78x | 0.62x | 0.78x | 0.89x | 0.75x | 0.88x | 0.85x |
Asset Growth % | 14.68% | 23.58% | 20.36% | -4.74% | 15.86% | 5.57% | 5.85% | 23.66% | -1.61% | 56% |
Total Current Liabilities | 14.24M | 14.95M | 17.19M | 18.71M | 18.92M | 28.91M | 23.73M | 29.29M | 37.33M | 43.05M |
Accounts Payable | 8.79M | 9.92M | 9.39M | 10.84M | 9.82M | 16.07M | 11.34M | 14.16M | 17.42M | 24.06M |
Days Payables Outstanding | 54.09 | 58.77 | 45.31 | 50.36 | 48.7 | 57.27 | 34.64 | 42.31 | 43.36 | 44.22 |
Short-Term Debt | 0 | 0 | 1.37M | 1.36M | 2.87M | 2.9M | 2M | 2.75M | 4.13M | 3.44M |
Deferred Revenue (Current) | 0 | -439K | 0 | 0 | 0 | 119K | 0 | 0 | 0 | 298K |
Other Current Liabilities | 168K | -121K | 0 | 0 | 4.39M | 6.93M | 287K | 298K | 15.79M | 15.56M |
Current Ratio | 4.35x | 4.50x | 4.09x | 3.45x | 3.52x | 2.73x | 3.80x | 3.32x | 2.83x | 2.56x |
Quick Ratio | 2.50x | 2.97x | 2.36x | 1.94x | 1.76x | 1.31x | 2.02x | 1.56x | 1.39x | 1.23x |
Cash Conversion Cycle | 170.5 | 143.61 | 201.21 | 151.98 | 190.99 | 166.4 | 167.43 | 176.36 | 155.87 | 153.99 |
Total Non-Current Liabilities | 3.9M | 623K | 17.62M | 2.07M | 22.87M | 23.11M | 29.12M | 56.97M | 49.45M | 47.83M |
Long-Term Debt | 0 | 0 | 15.78M | 0 | 18.86M | 19.31M | 23.62M | 51.5M | 45.53M | 0 |
Capital Lease Obligations | 0 | 376K | 1.25M | 1.52M | 1.74M | 1.31M | 2.64M | 3M | 0 | 5.07M |
Deferred Tax Liabilities | 3.9M | 623K | 559K | 515K | 2.25M | 1.92M | 1.71M | 0 | 1M | 3.33M |
Other Non-Current Liabilities | 0 | -344K | -528K | 1.56M | 17K | 17K | 1.14M | 2.47M | 2.92M | 46.87M |
Total Liabilities | 18.14M | 15.57M | 34.81M | 20.78M | 41.8M | 52.03M | 52.85M | 86.26M | 86.78M | 90.89M |
Total Debt | 0 | 815K | 19.02M | 3.56M | 23.47M | 23.51M | 29.16M | 58.39M | 49.65M | 3.44M |
Net Debt | -18.33M | -25.12M | 11.61M | -7.09M | 15.05M | 17.8M | 18.88M | 51.53M | 40.31M | -5.45M |
Debt / Equity | - | 0.01x | 0.17x | 0.03x | 0.20x | 0.20x | 0.23x | 0.44x | 0.38x | 0.03x |
Debt / EBITDA | - | 0.09x | 1.88x | 0.41x | 6.57x | 5.12x | 2.18x | 4.13x | 3.37x | 0.37x |
Net Debt / EBITDA | -2.06x | -2.81x | 1.15x | -0.82x | 4.21x | 3.88x | 1.41x | 3.65x | 2.74x | -0.59x |
Interest Coverage | 35.39x | 104.05x | 13.56x | 17.11x | 0.38x | 0.53x | 5.52x | 5.28x | 2.33x | 1.02x |
Total Equity | 79.05M▲ 0% | 104.53M▲ 32.2% | 109.75M▲ 5.0% | 116.92M▲ 6.5% | 117.74M▲ 0.7% | 116.4M▼ 1.1% | 125.43M▲ 7.8% | 134.19M▲ 7.0% | 130.13M▼ 3.0% | 129.75M▲ 0% |
Equity Growth % | 16.49% | 32.24% | 4.99% | 6.54% | 0.7% | -1.14% | 7.75% | 6.98% | -3.02% | -1.98% |
Book Value per Share | 4.98 | 6.39 | 6.78 | 7.26 | 7.34 | 7.22 | 7.73 | 8.00 | 7.82 | 7.79 |
Total Shareholders' Equity | 79.2M | 104.62M | 109.73M | 116.8M | 117.62M | 116.28M | 125.33M | 134M | 130M | 129.63M |
Common Stock | 1.97M | 2M | 2.03M | 2.04M | 2.05M | 2.06M | 2.08M | 2.11M | 2.11M | 2.11M |
Retained Earnings | -82.89M | -57.96M | -52.83M | -47.6M | -47.83M | -47.95M | -40.75M | -34.44M | -40.34M | -40.79M |
Treasury Stock | -18.47M | -19.27M | -21.23M | -21.32M | -21.47M | -21.48M | -21.49M | -21.49M | -21.49M | 0 |
Accumulated OCI | -1.61M | -2.79M | -2.53M | -1.78M | -1.65M | -3.75M | -3.66M | -4.01M | -3.14M | -3.06M |
Minority Interest | -154K | -85K | 24K | 123K | 127K | 126K | 95K | 192K | 139K | 119K |
ULBI Cash Flow Statement
Ultralife Corporation (ULBI) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 7.27M | 10.89M | -2.97M | 21.72M | 4.33M | -1.26M | 1.93M | 16.64M | 10.99M | 9.85M |
Operating CF Margin % | 8.5% | 12.49% | -2.78% | 20.16% | 4.4% | -0.96% | 1.22% | 10.12% | 5.75% | - |
Operating CF Growth % | -5% | 49.74% | -127.28% | 831.31% | -80.09% | -129.2% | 252.73% | 762.42% | -33.94% | -213.97% |
Net Income | 7.66M | 25M | 5.31M | 5.33M | -230K | -120K | 7.2M | 6.41M | -5.9M | -8.21M |
Depreciation & Amortization | 2.43M | 2.37M | 2.75M | 2.94M | 3.54M | 4.46M | 3.91M | 4.16M | 5.5M | 5.46M |
Stock-Based Compensation | 653K | 890K | 753K | 943K | 671K | 776K | 528K | 698K | 935K | 0 |
Deferred Taxes | -1.67M | -18.64M | 1.21M | 1.39M | -147K | -962K | 1.3M | 1.23M | -2.54M | -3.21M |
Other Non-Cash Items | 47K | 36K | 44K | -1.54M | 104K | 36K | 33K | 253K | 12.39M | 13.04M |
Working Capital Changes | -1.85M | 1.24M | -13.04M | 12.67M | 388K | -5.45M | -11.04M | 3.89M | 602K | 2.77M |
Change in Receivables | -1.29M | -1.51M | -10.42M | 9.21M | 4.42M | -7.88M | -3.89M | 7.6M | -4.35M | 1.73M |
Change in Inventory | -2.54M | 3.19M | -2.2M | 1.8M | -1.3M | -8.75M | -943K | -109K | -2.35M | -9.27M |
Change in Payables | 2.66M | -822K | 1.13M | 1.65M | -2.71M | 10.09M | -2.97M | 215K | 5.78M | 10.27M |
Cash from Investing | -1.39M | -4.18M | -31.53M | -2.98M | -26.33M | -1.68M | -2.55M | -49.95M | -3.87M | -3.75M |
Capital Expenditures | -1.39M | -4.18M | -6.28M | -3.1M | -2.81M | -1.68M | -2.55M | -1.93M | -3.87M | -3.75M |
CapEx % of Revenue | 1.63% | 4.8% | 5.88% | 2.88% | 2.86% | 1.27% | 1.61% | 1.17% | 2.03% | 1.99% |
Acquisitions | 0 | 0 | -25.25M | 120K | -23.52M | 0 | 0 | -48.02M | 0 | 0 |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | 0 | -4.18M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash from Financing | 1.4M | 1.17M | 16.12M | -15.69M | 19.64M | 518K | 5.49M | 29.86M | -4.68M | -6.03M |
Debt Issued (Net) | 0 | 0 | 17.32M | -15.84M | 19.51M | 517K | 4.25M | 29.25M | -4.75M | -6.13M |
Equity Issued (Net) | 0 | -797K | -1.96M | 238K | 398K | 116K | -8K | 2M | 98K | 98K |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | -26K | -742K | -1.96M | 0 | -148K | -15K | -8K | 0 | 0 | 0 |
Other Financing | 1.4M | 1.97M | 765K | -90K | -262K | -115K | 1.25M | -1.39M | -24K | 0 |
Net Change in Cash | 7.61M▲ 0% | 7.6M▼ 0.1% | -18.53M▼ 343.7% | 3.25M▲ 117.5% | -2.24M▼ 169.0% | -2.7M▼ 20.5% | 4.57M▲ 269.1% | -3.42M▼ 175.0% | 2.49M▲ 172.8% | 171K▲ 0% |
Free Cash Flow | 5.88M▲ 0% | 6.7M▲ 14.0% | -9.25M▼ 238.1% | 18.62M▲ 301.3% | 1.51M▼ 91.9% | -2.94M▼ 294.7% | -623K▲ 78.8% | 14.7M▲ 2460.2% | 7.12M▼ 51.6% | 6.11M▲ 0% |
FCF Margin % | 6.87% | 7.69% | -8.66% | 17.29% | 1.54% | -2.23% | -0.39% | 8.94% | 3.72% | 3.25% |
FCF Growth % | -8.64% | 14% | -238.05% | 301.26% | -91.88% | -294.71% | 78.82% | 2460.19% | -51.59% | -65.36% |
FCF per Share | 0.37 | 0.41 | -0.57 | 1.16 | 0.09 | -0.18 | -0.04 | 0.88 | 0.43 | 0.37 |
FCF Conversion (FCF/Net Income) | 0.95x | 0.44x | -0.57x | 4.15x | -18.48x | 10.61x | 0.27x | 2.64x | -1.86x | -0.74x |
Interest Paid | 102K | 132K | 576K | 375K | 142K | 930K | 1.96M | 1.85M | 0 | 0 |
Taxes Paid | 345K | 220K | 266K | 264K | 324K | 354K | 769K | 722K | 0 | 0 |
ULBI Key Ratios
Ultralife Corporation (ULBI) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 10.41% | 27.16% | 4.86% | 4.62% | -0.2% | -0.1% | 5.95% | 4.86% | -4.46% | -6.13% |
Return on Invested Capital (ROIC) | 8.24% | 7.02% | 5.5% | 3.7% | 0.02% | 0.07% | 5.1% | 4.53% | 3.88% | 1.75% |
Gross Margin | 30.67% | 29.34% | 29.18% | 27.07% | 25.08% | 22.3% | 24.71% | 25.73% | 23.28% | 22.36% |
Net Margin | 8.94% | 28.59% | 4.87% | 4.86% | -0.24% | -0.09% | 4.54% | 3.84% | -3.09% | -4.37% |
Debt / Equity | - | 0.01x | 0.17x | 0.03x | 0.20x | 0.20x | 0.23x | 0.44x | 0.38x | 0.03x |
Interest Coverage | 35.39x | 104.05x | 13.56x | 17.11x | 0.38x | 0.53x | 5.52x | 5.28x | 2.33x | 1.02x |
FCF Conversion | 0.95x | 0.44x | -0.57x | 4.15x | -18.48x | 10.61x | 0.27x | 2.64x | -1.86x | -0.74x |
Revenue Growth | 3.72% | 1.94% | 22.49% | 0.86% | -8.77% | 34.17% | 20.33% | 3.66% | 16.24% | 8.42% |
Related:ULBI Dividend History·ULBI Revenue History·ULBI Price History·ULBI P/E History·ULBI Financial Ratios·ULBI Institutional Holders
ULBI SEC Filings & Documents
Ultralife Corporation (ULBI) SEC filings — annual & quarterly reports (10-K, 10-Q)
ULBI Frequently Asked Questions
Ultralife Corporation (ULBI) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Ultralife Corporation (ULBI) reported $187.9M in revenue for fiscal year 2025. This represents a 1144% increase from $15.1M in 1996.
Ultralife Corporation (ULBI) grew revenue by 16.2% over the past year. This is strong growth.
Ultralife Corporation (ULBI) reported a net loss of $8.2M for fiscal year 2025.
Dividend & Returns
Ultralife Corporation (ULBI) has a return on equity (ROE) of -4.5%. Negative ROE indicates the company is unprofitable.
Ultralife Corporation (ULBI) generated $6.1M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.